Oman Pharmaceuticals & Healthcare Q4 2018
Oman's pharmaceutical market has been historically supported by high per capita incomes, a strong public healthcaresystem and a significant underlying burden of chronic disease. However, manufacturers will face an increasingly cost-consciouspublic sector in light of government budget constraints. Phased pharmaceutical price reductions pose near-term risks formanufacturers and importers.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook